THOMAS TOOLE: Open Payments
NPI 1962081638 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 15 payments from 11 companies in 2025. Trend: 2023 $427 · 2024 $643 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: GEMTESA, AIRSUPRA, FARXIGA, Veozah, PREVNAR 20, Cologuard Collection Kit, REXULTI, AREXVY.
Industry payments across TX — which companies pay providers there.
